跳至主要内容
临床试验/DRKS00022083
DRKS00022083已完成未知

Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact persons’ immune status and termination of quarantine and self-isolation – a prospective pilot study - SARS-CoV-2 PoC/ELISA

andesklinikum Neunkirchen0 个研究点目标入组 130 人开始时间: 2020年6月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • All employees of the university hospital Krems with age >18 years, and with a history of direct contact to a COVID-19 patient without full personal protective equipment may be included.
  • Written consent to participate in the study is mandatory.

排除标准

  • absence of consent; age <18 years; inadequate language skills for study information

研究者

发起方
andesklinikum Neunkirchen

相似试验